During the last 15 years, accumulating evidence has implicated aluminum in disorders associated with chronic renal failure.’6 The well-recognized manifestations of systemic aluminum toxicity include fracturing osteomalacia, dialysis encephalopathy, and microcytic hypochromic anemia. More recently, aluminum loading has been demonstrated in premature infants receiving intravenous fluid therapy.7 ...

During the last 15 years, accumulating evidence has implicated aluminum in disorders associated with chronic renal failure.’6 The well-recognized manifestations of systemic aluminum toxicity include fracturing osteomalacia, dialysis encephalopathy, and microcytic hypochromic anemia. More recently, aluminum loading has been demonstrated in premature infants receiving intravenous fluid therapy.7 ...

During the last 15 years, accumulating evidence has implicated aluminum in disorders associated with chronic renal failure.’6 The well-recognized manifestations of systemic aluminum toxicity include fracturing osteomalacia, dialysis encephalopathy, and microcytic hypochromic anemia. More recently, aluminum loading has been demonstrated in premature infants receiving intravenous fluid therapy.7 ...

During the last 15 years, accumulating evidence has implicated aluminum in disorders associated with chronic renal failure.’6 The well-recognized manifestations of systemic aluminum toxicity include fracturing osteomalacia, dialysis encephalopathy, and microcytic hypochromic anemia. More recently, aluminum loading has been demonstrated in premature infants receiving intravenous fluid therapy.7 ...

During the last 15 years, accumulating evidence has implicated aluminum in disorders associated with chronic renal failure.’6 The well-recognized manifestations of systemic aluminum toxicity include fracturing osteomalacia, dialysis encephalopathy, and microcytic hypochromic anemia. More recently, aluminum loading has been demonstrated in premature infants receiving intravenous fluid therapy.7 ...

During the last 15 years, accumulating evidence has implicated aluminum in disorders associated with chronic renal failure.’6 The well-recognized manifestations of systemic aluminum toxicity include fracturing osteomalacia, dialysis encephalopathy, and microcytic hypochromic anemia. More recently, aluminum loading has been demonstrated in premature infants receiving intravenous fluid therapy.7 ...

During the last 15 years, accumulating evidence has implicated aluminum in disorders associated with chronic renal failure.’6 The well-recognized manifestations of systemic aluminum toxicity include fracturing osteomalacia, dialysis encephalopathy, and microcytic hypochromic anemia. More recently, aluminum loading has been demonstrated in premature infants receiving intravenous fluid therapy.7 ...

the influence of aluminum on some serum parameters related to bone metabolism has been investigated by daily administration of aluminum over different periods of time. daily administration of aluminum (1 mg/kg bw) for 20 or 50 days elevated serum phosphorous concentration by 16 percent and had no significant effect on serum calcium level. when aluminum was injected as a complex with citric acid...

Ferric citrate hydrate was recently approved in Japan as an oral phosphate binder to be taken with food for the control of hyperphosphatemia in patients with chronic kidney disease (CKD). The daily therapeutic dose is about 3 to 6 g, which comprises about 2 to 4 g of citrate. Oral citrate solubilizes aluminum that is present in food and drinking water, and opens the tight junctions in the intes...

MicroRNAs are small 21-nucleotide RNA molecules with regulatory roles in development and in response to stress. Expression of some plant miRNAs has been specifically associated with responses to abiotic stresses caused by cold, light, iron, and copper ions. In acid soils, aluminum solubility increases, thereby causing severe damage to plants. Although physiological aspects of aluminum toxi...